Showing results (71-80 of 131) with videos related to
Sort By:
Pageof 14
Oncotarget|November 29, 2017
BCRP expression in schwannoma, plexiform neurofibroma and MPNSTMaurits de Vries, Olaf van Tellingen, Andel G L van der Mey, et al.Analytical Biochemistry|December 5, 2003
Development and validation of a method to determine the unbound paclitaxel fraction in human plasmaH J G Desirée van den Bongard, E Marleen Kemper, Olaf van Tellingen, et al.Cancer Research|August 18, 2004
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactionsPauline Breedveld, Noam Zelcer, Dick Pluim, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 19, 2015
Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft modelLília R Cordeiro Pedrosa, Olaf van Tellingen, Thomas Soullié, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2021
Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specificationsLennart J van Winden, Mirthe Lanfermeijer, Annemieke C Heijboer, et al.Journal of Neuropathology and Experimental Neurology|January 31, 2020
Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis PatientsErwin A van Vliet, Anand M Iyer, Lucia Mesarosova, et al.Molecular Cancer Therapeutics|December 20, 2007
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti, Roos L Oostendorp, Dick Pluim, et al.Genes|July 27, 2022
Tooth Formation as Experimental Model to Study Chemotherapy on Tissue Development: Effect of a Specific Dose of Temozolomide/VeliparibSali Al-Ansari, Rozita Jalali, Antonius L J J Bronckers, et al.Biotechniques|October 16, 2007
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animalsClara P W Klerk, Renée M Overmeer, Tatjana M H Niers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2016
PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.Pageof 14